557 related articles for article (PubMed ID: 26756635)
1. Glucose Transporters in Cardiac Metabolism and Hypertrophy.
Shao D; Tian R
Compr Physiol; 2015 Dec; 6(1):331-51. PubMed ID: 26756635
[TBL] [Abstract][Full Text] [Related]
2. Glucose metabolism and cardiac hypertrophy.
Kolwicz SC; Tian R
Cardiovasc Res; 2011 May; 90(2):194-201. PubMed ID: 21502371
[TBL] [Abstract][Full Text] [Related]
3. Glucose is preferentially utilized for biomass synthesis in pressure-overloaded hearts: evidence from fatty acid-binding protein-4 and -5 knockout mice.
Umbarawan Y; Syamsunarno MRAA; Koitabashi N; Yamaguchi A; Hanaoka H; Hishiki T; Nagahata-Naito Y; Obinata H; Sano M; Sunaga H; Matsui H; Tsushima Y; Suematsu M; Kurabayashi M; Iso T
Cardiovasc Res; 2018 Jul; 114(8):1132-1144. PubMed ID: 29554241
[TBL] [Abstract][Full Text] [Related]
4. Hearts lacking caveolin-1 develop hypertrophy with normal cardiac substrate metabolism.
Augustus AS; Buchanan J; Gutman E; Rengo G; Pestell RG; Fortina P; Koch WJ; Bensadoun A; Abel ED; Lisanti MP
Cell Cycle; 2008 Aug; 7(16):2509-18. PubMed ID: 18719368
[TBL] [Abstract][Full Text] [Related]
5. Metabolic impairment in response to early induction of C/EBPβ leads to compromised cardiac function during pathological hypertrophy.
Banerjee D; Datta Chaudhuri R; Niyogi S; Roy Chowdhuri S; Poddar Sarkar M; Chatterjee R; Chakrabarti P; Sarkar S
J Mol Cell Cardiol; 2020 Feb; 139():148-163. PubMed ID: 31958467
[TBL] [Abstract][Full Text] [Related]
6. Glucose transporters in cardiovascular system in health and disease.
Bertrand L; Auquier J; Renguet E; Angé M; Cumps J; Horman S; Beauloye C
Pflugers Arch; 2020 Sep; 472(9):1385-1399. PubMed ID: 32809061
[TBL] [Abstract][Full Text] [Related]
7. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy.
Zhang L; Jaswal JS; Ussher JR; Sankaralingam S; Wagg C; Zaugg M; Lopaschuk GD
Circ Heart Fail; 2013 Sep; 6(5):1039-48. PubMed ID: 23861485
[TBL] [Abstract][Full Text] [Related]
8. Changes in cardiac substrate transporters and metabolic proteins mirror the metabolic shift in patients with aortic stenosis.
Heather LC; Howell NJ; Emmanuel Y; Cole MA; Frenneaux MP; Pagano D; Clarke K
PLoS One; 2011; 6(10):e26326. PubMed ID: 22028857
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of energy substrate metabolism in normal and hypertrophied heart.
Tian R
Curr Hypertens Rep; 2003 Dec; 5(6):454-8. PubMed ID: 14594563
[TBL] [Abstract][Full Text] [Related]
10. Contribution of glycogen and exogenous glucose to glucose metabolism during ischemia in the hypertrophied rat heart.
Schönekess BO; Allard MF; Henning SL; Wambolt RB; Lopaschuk GD
Circ Res; 1997 Oct; 81(4):540-9. PubMed ID: 9314835
[TBL] [Abstract][Full Text] [Related]
11. Coordinate regulation of metabolic enzyme encoding genes during cardiac development and following carvedilol therapy in spontaneously hypertensive rats.
Sack MN; Harrington LS; Jonassen AK; Mjøs OD; Yellon DM
Cardiovasc Drugs Ther; 2000 Feb; 14(1):31-9. PubMed ID: 10755198
[TBL] [Abstract][Full Text] [Related]
12. Glucose transporter 4-deficient hearts develop maladaptive hypertrophy in response to physiological or pathological stresses.
Wende AR; Kim J; Holland WL; Wayment BE; O'Neill BT; Tuinei J; Brahma MK; Pepin ME; McCrory MA; Luptak I; Halade GV; Litwin SE; Abel ED
Am J Physiol Heart Circ Physiol; 2017 Dec; 313(6):H1098-H1108. PubMed ID: 28822962
[TBL] [Abstract][Full Text] [Related]
13. Glucose transporters in healthy heart and in cardiac disease.
Szablewski L
Int J Cardiol; 2017 Mar; 230():70-75. PubMed ID: 28034463
[TBL] [Abstract][Full Text] [Related]
14. Substrate uptake and metabolism are preserved in hypertrophic caveolin-3 knockout hearts.
Augustus AS; Buchanan J; Addya S; Rengo G; Pestell RG; Fortina P; Koch WJ; Bensadoun A; Abel ED; Lisanti MP
Am J Physiol Heart Circ Physiol; 2008 Aug; 295(2):H657-66. PubMed ID: 18552160
[TBL] [Abstract][Full Text] [Related]
15. Energy substrate metabolism in cardiac hypertrophy.
Allard MF
Curr Hypertens Rep; 2004 Dec; 6(6):430-5. PubMed ID: 15527686
[TBL] [Abstract][Full Text] [Related]
16. Pivotal role of membrane substrate transporters on the metabolic alterations in the pressure-overloaded heart.
Geraets IME; Glatz JFC; Luiken JJFP; Nabben M
Cardiovasc Res; 2019 May; 115(6):1000-1012. PubMed ID: 30938418
[TBL] [Abstract][Full Text] [Related]
17. Exercise-Induced Changes in Glucose Metabolism Promote Physiological Cardiac Growth.
Gibb AA; Epstein PN; Uchida S; Zheng Y; McNally LA; Obal D; Katragadda K; Trainor P; Conklin DJ; Brittian KR; Tseng MT; Wang J; Jones SP; Bhatnagar A; Hill BG
Circulation; 2017 Nov; 136(22):2144-2157. PubMed ID: 28860122
[TBL] [Abstract][Full Text] [Related]
18. Regulation of sarcolemmal transport of substrates in the healthy and diseased heart.
Glatz JF; Bonen A; Ouwens DM; Luiken JJ
Cardiovasc Drugs Ther; 2006 Dec; 20(6):471-6. PubMed ID: 17119873
[TBL] [Abstract][Full Text] [Related]
19. Metabolic Remodeling Promotes Cardiac Hypertrophy by Directing Glucose to Aspartate Biosynthesis.
Ritterhoff J; Young S; Villet O; Shao D; Neto FC; Bettcher LF; Hsu YA; Kolwicz SC; Raftery D; Tian R
Circ Res; 2020 Jan; 126(2):182-196. PubMed ID: 31709908
[TBL] [Abstract][Full Text] [Related]
20. Energy metabolism and mechanical recovery after cardioplegia in moderately hypertrophied rats.
Smolenski RT; Jayakumar J; Seymour AM; Yacoub MH
Mol Cell Biochem; 1998 Mar; 180(1-2):137-43. PubMed ID: 9546640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
